APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contract Pharmaceutical Manufacturing

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Selected research

Market Analysis & Forecast

Global Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2026-2032

21 December 2025205 pages

Choose your research edition.

Industry ResearchContract Pharmaceutical Manufacturing Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Contract Pharmaceutical Manufacturing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Contract Pharmaceutical Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contract Pharmaceutical Manufacturing Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.

North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.

Read the full market overview

In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.

Report Includes

This report presents an overview of global market for Contract Pharmaceutical Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Contract Pharmaceutical Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Contract Pharmaceutical Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contract Pharmaceutical Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Contract Pharmaceutical Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Contract Pharmaceutical Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Contract Pharmaceutical Manufacturing Segment by Company

Catalent

DPx

Lonza

Piramal Healthcare

Aenova

Jubilant

Famar

Boehringer Ingelheim

Fareva Holding

AbbVie

Nipro Corp

Vetter

Sopharma

DPT Laboratories

Recipharm

NextPharma

Dishman

Aesica

Contract Pharmaceutical Manufacturing Segment by Type

Oral

Injectable

API

Other

Contract Pharmaceutical Manufacturing Segment by Application

Large Enterprise

Small Medium Enterprise

Contract Pharmaceutical Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contract Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Pharmaceutical Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Contract Pharmaceutical Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Player Table 3. Injectable Major Player Table 4. API Major Player Table 5. Other Major Player Table 6. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Large Enterprise Major Player Table 8. Small Medium Enterprise Major Player Table 9. Contract Pharmaceutical Manufacturing Industry Trends Table 10. Contract Pharmaceutical Manufacturing Industry Drivers Table 11. Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges Table 12. Contract Pharmaceutical Manufacturing Industry Restraints Table 13. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Contract Pharmaceutical Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Contract Pharmaceutical Manufacturing Market Share by Region (2021-2026) Table 16. Global Contract Pharmaceutical Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Contract Pharmaceutical Manufacturing Market Share by Region (2027-2032) Table 18. Global Contract Pharmaceutical Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2021-2026) Table 20. Global Contract Pharmaceutical Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Contract Pharmaceutical Manufacturing Key Players Headquarters & Area Served Table 22. Global Contract Pharmaceutical Manufacturing Players, Product Type & Application Table 23. Global Contract Pharmaceutical Manufacturing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Contract Pharmaceutical Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Contract Pharmaceutical Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021-2026) Table 30. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2027-2032) Table 31. Global Contract Pharmaceutical Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021-2026) Table 35. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2027-2032) Table 36. Catalent Company Information Table 37. Catalent Business Overview Table 38. Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Catalent Contract Pharmaceutical Manufacturing Product Portfolio Table 40. Catalent Recent Development Table 41. DPx Company Information Table 42. DPx Business Overview Table 43. DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. DPx Contract Pharmaceutical Manufacturing Product Portfolio Table 45. DPx Recent Development Table 46. Lonza Company Information Table 47. Lonza Business Overview Table 48. Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Lonza Contract Pharmaceutical Manufacturing Product Portfolio Table 50. Lonza Recent Development Table 51. Piramal Healthcare Company Information Table 52. Piramal Healthcare Business Overview Table 53. Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio Table 55. Piramal Healthcare Recent Development Table 56. Aenova Company Information Table 57. Aenova Business Overview Table 58. Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Aenova Contract Pharmaceutical Manufacturing Product Portfolio Table 60. Aenova Recent Development Table 61. Jubilant Company Information Table 62. Jubilant Business Overview Table 63. Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Jubilant Contract Pharmaceutical Manufacturing Product Portfolio Table 65. Jubilant Recent Development Table 66. Famar Company Information Table 67. Famar Business Overview Table 68. Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Famar Contract Pharmaceutical Manufacturing Product Portfolio Table 70. Famar Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Fareva Holding Company Information Table 77. Fareva Holding Business Overview Table 78. Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio Table 80. Fareva Holding Recent Development Table 81. AbbVie Company Information Table 82. AbbVie Business Overview Table 83. AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AbbVie Contract Pharmaceutical Manufacturing Product Portfolio Table 85. AbbVie Recent Development Table 86. Nipro Corp Company Information Table 87. Nipro Corp Business Overview Table 88. Nipro Corp Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio Table 90. Nipro Corp Recent Development Table 91. Vetter Company Information Table 92. Vetter Business Overview Table 93. Vetter Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Vetter Contract Pharmaceutical Manufacturing Product Portfolio Table 95. Vetter Recent Development Table 96. Sopharma Company Information Table 97. Sopharma Business Overview Table 98. Sopharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Sopharma Contract Pharmaceutical Manufacturing Product Portfolio Table 100. Sopharma Recent Development Table 101. DPT Laboratories Company Information Table 102. DPT Laboratories Business Overview Table 103. DPT Laboratories Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio Table 105. DPT Laboratories Recent Development Table 106. Recipharm Company Information Table 107. Recipharm Business Overview Table 108. Recipharm Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Recipharm Contract Pharmaceutical Manufacturing Product Portfolio Table 110. Recipharm Recent Development Table 111. NextPharma Company Information Table 112. NextPharma Business Overview Table 113. NextPharma Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. NextPharma Contract Pharmaceutical Manufacturing Product Portfolio Table 115. NextPharma Recent Development Table 116. Dishman Company Information Table 117. Dishman Business Overview Table 118. Dishman Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Dishman Contract Pharmaceutical Manufacturing Product Portfolio Table 120. Dishman Recent Development Table 121. Aesica Company Information Table 122. Aesica Business Overview Table 123. Aesica Contract Pharmaceutical Manufacturing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Aesica Contract Pharmaceutical Manufacturing Product Portfolio Table 125. Aesica Recent Development Table 126. North America Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 127. North America Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 128. North America Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 132. North America Contract Pharmaceutical Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 133. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 134. Europe Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 135. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 139. Europe Contract Pharmaceutical Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 140. China Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 141. China Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 142. China Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 143. China Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 145. Asia Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 146. Asia Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 147. Asia Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Contract Pharmaceutical Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Contract Pharmaceutical Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 150. Asia Contract Pharmaceutical Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 151. SAMEA Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 152. SAMEA Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 153. SAMEA Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 154. SAMEA Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 155. SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 157. SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Contract Pharmaceutical Manufacturing Image Figure 2. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contract Pharmaceutical Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injectable Image Figure 6. API Image Figure 7. Other Image Figure 8. Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Contract Pharmaceutical Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Large Enterprise Image Figure 11. Small Medium Enterprise Image Figure 12. Global Contract Pharmaceutical Manufacturing Market Size (US$ Million) & (2021-2032) Figure 13. Global Contract Pharmaceutical Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Contract Pharmaceutical Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Contract Pharmaceutical Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Contract Pharmaceutical Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Contract Pharmaceutical Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021-2032) Figure 20. Global Contract Pharmaceutical Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021-2032) Figure 23. North America Contract Pharmaceutical Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032) Figure 25. North America Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032) Figure 26. North America Contract Pharmaceutical Manufacturing Revenue Share by Country (2021-2032) Figure 27. United States Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Contract Pharmaceutical Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032) Figure 32. Europe Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032) Figure 33. Europe Contract Pharmaceutical Manufacturing Revenue Share by Country (2021-2032) Figure 34. Germany Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Contract Pharmaceutical Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032) Figure 44. China Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032) Figure 45. Asia Contract Pharmaceutical Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032) Figure 47. Asia Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032) Figure 48. Asia Contract Pharmaceutical Manufacturing Revenue Share by Region (2021-2032) Figure 49. Japan Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Contract Pharmaceutical Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032) Figure 57. SAMEA Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032) Figure 58. SAMEA Contract Pharmaceutical Manufacturing Revenue Share by Country (2021-2032) Figure 59. Brazil Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Contract Pharmaceutical Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectable
  • API
  • Other
Applications
  • Large Enterprise
  • Small Medium Enterprise
Companies covered
  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Contract Pharmaceutical Manufacturing Market by Type
  3. 1.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injectable
  6. 1.2.4 API
  7. 1.2.5 Other
  8. 1.3 Contract Pharmaceutical Manufacturing Market by Application
  9. 1.3.1 Global Contract Pharmaceutical Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Large Enterprise
  11. 1.3.3 Small Medium Enterprise
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Contract Pharmaceutical Manufacturing Market Dynamics
  1. 2.1 Contract Pharmaceutical Manufacturing Industry Trends
  2. 2.2 Contract Pharmaceutical Manufacturing Industry Drivers
  3. 2.3 Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges
  4. 2.4 Contract Pharmaceutical Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Contract Pharmaceutical Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global Contract Pharmaceutical Manufacturing Growth Trends by Region
  3. 3.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Contract Pharmaceutical Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global Contract Pharmaceutical Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Contract Pharmaceutical Manufacturing Revenue by Players
  2. 4.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Contract Pharmaceutical Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Contract Pharmaceutical Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Contract Pharmaceutical Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global Contract Pharmaceutical Manufacturing Players, Product Type & Application
  8. 4.5 Global Contract Pharmaceutical Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Contract Pharmaceutical Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 Contract Pharmaceutical Manufacturing Tier 1, Tier 2, and Tier 3
5 Contract Pharmaceutical Manufacturing Market Size by Type
  1. 5.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2021-2032)
6 Contract Pharmaceutical Manufacturing Market Size by Application
  1. 6.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Catalent
  2. 7.1.1 Catalent Company Information
  3. 7.1.2 Catalent Business Overview
  4. 7.1.3 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio
  6. 7.1.5 Catalent Recent Developments
  7. 7.2 DPx
  8. 7.2.1 DPx Company Information
  9. 7.2.2 DPx Business Overview
  10. 7.2.3 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio
  12. 7.2.5 DPx Recent Developments
  13. 7.3 Lonza
  14. 7.3.1 Lonza Company Information
  15. 7.3.2 Lonza Business Overview
  16. 7.3.3 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio
  18. 7.3.5 Lonza Recent Developments
  19. 7.4 Piramal Healthcare
  20. 7.4.1 Piramal Healthcare Company Information
  21. 7.4.2 Piramal Healthcare Business Overview
  22. 7.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio
  24. 7.4.5 Piramal Healthcare Recent Developments
  25. 7.5 Aenova
  26. 7.5.1 Aenova Company Information
  27. 7.5.2 Aenova Business Overview
  28. 7.5.3 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio
  30. 7.5.5 Aenova Recent Developments
  31. 7.6 Jubilant
  32. 7.6.1 Jubilant Company Information
  33. 7.6.2 Jubilant Business Overview
  34. 7.6.3 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio
  36. 7.6.5 Jubilant Recent Developments
  37. 7.7 Famar
  38. 7.7.1 Famar Company Information
  39. 7.7.2 Famar Business Overview
  40. 7.7.3 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio
  42. 7.7.5 Famar Recent Developments
  43. 7.8 Boehringer Ingelheim
  44. 7.8.1 Boehringer Ingelheim Company Information
  45. 7.8.2 Boehringer Ingelheim Business Overview
  46. 7.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio
  48. 7.8.5 Boehringer Ingelheim Recent Developments
  49. 7.9 Fareva Holding
  50. 7.9.1 Fareva Holding Company Information
  51. 7.9.2 Fareva Holding Business Overview
  52. 7.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio
  54. 7.9.5 Fareva Holding Recent Developments
  55. 7.10 AbbVie
  56. 7.10.1 AbbVie Company Information
  57. 7.10.2 AbbVie Business Overview
  58. 7.10.3 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio
  60. 7.10.5 AbbVie Recent Developments
  61. 7.11 Nipro Corp
  62. 7.11.1 Nipro Corp Company Information
  63. 7.11.2 Nipro Corp Business Overview
  64. 7.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio
  66. 7.11.5 Nipro Corp Recent Developments
  67. 7.12 Vetter
  68. 7.12.1 Vetter Company Information
  69. 7.12.2 Vetter Business Overview
  70. 7.12.3 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio
  72. 7.12.5 Vetter Recent Developments
  73. 7.13 Sopharma
  74. 7.13.1 Sopharma Company Information
  75. 7.13.2 Sopharma Business Overview
  76. 7.13.3 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio
  78. 7.13.5 Sopharma Recent Developments
  79. 7.14 DPT Laboratories
  80. 7.14.1 DPT Laboratories Company Information
  81. 7.14.2 DPT Laboratories Business Overview
  82. 7.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio
  84. 7.14.5 DPT Laboratories Recent Developments
  85. 7.15 Recipharm
  86. 7.15.1 Recipharm Company Information
  87. 7.15.2 Recipharm Business Overview
  88. 7.15.3 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio
  90. 7.15.5 Recipharm Recent Developments
  91. 7.16 NextPharma
  92. 7.16.1 NextPharma Company Information
  93. 7.16.2 NextPharma Business Overview
  94. 7.16.3 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio
  96. 7.16.5 NextPharma Recent Developments
  97. 7.17 Dishman
  98. 7.17.1 Dishman Company Information
  99. 7.17.2 Dishman Business Overview
  100. 7.17.3 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio
  102. 7.17.5 Dishman Recent Developments
  103. 7.18 Aesica
  104. 7.18.1 Aesica Company Information
  105. 7.18.2 Aesica Business Overview
  106. 7.18.3 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio
  108. 7.18.5 Aesica Recent Developments
8 North America
  1. 8.1 North America Contract Pharmaceutical Manufacturing Revenue (2021-2032)
  2. 8.2 North America Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America Contract Pharmaceutical Manufacturing Revenue by Country
  11. 8.6.1 North America Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America Contract Pharmaceutical Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Contract Pharmaceutical Manufacturing Revenue (2021-2032)
  2. 9.2 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Contract Pharmaceutical Manufacturing Revenue by Country
  11. 9.6.1 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Contract Pharmaceutical Manufacturing Revenue (2021-2032)
  2. 10.2 China Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Contract Pharmaceutical Manufacturing Revenue (2021-2032)
  2. 11.2 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Contract Pharmaceutical Manufacturing Revenue by Country
  11. 11.6.1 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Contract Pharmaceutical Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA Contract Pharmaceutical Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Contract Pharmaceutical Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Contract Pharmaceutical Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Contract Pharmaceutical Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Contract Pharmaceutical Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Contract Pharmaceutical Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Contract Pharmaceutical Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Contract Pharmaceutical Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Contract Pharmaceutical Manufacturing Revenue by Country
  11. 12.6.1 SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Contract Pharmaceutical Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst